India Remdesivir Supplies: 'Peculiar' Situation, Flip Flops And Bangladesh Touch
Executive Summary
There's an action-packed run up to remdesivir supply plans in India replete with politics, with one state initially veering towards sourcing the potential COVID-19 treatment from Bangladesh, while pricing debate rumbles on. Indian licensees are now believed to have inched close to regulatory approval.
You may also be interested in...
India Remdesivir Supply Gap May Normalize Soon, But No End To Greed
India generic remdesivir supply situation seen improving soon, with existing players Cipla and Hetero ramping up the antiviral and the arrival of new entrant Mylan. But will that be enough to control black marketing of the investigational COVID-19 therapy? The government is also keeping a close watch on the goings on.
India Remdesivir Black Market: Supply Gap May Normalize Soon, But No End To Greed
India generic remdesivir supply situation seen improving soon, with existing players Cipla and Hetero ramping up the antiviral and the arrival of new entrant Mylan. But will that be enough to control black marketing of the investigational COVID-19 therapy? The government is also keeping a close watch on the goings on.
Coronavirus Update: Regeneron Gets Warp Speed Funding, Conflict Slowing Moderna's Progress
Operation Warp Speed extends its funding beyond vaccines into antibodies, while insiders say friction between Moderna and US government scientists has caused delays.